This Purchase Order contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2019 on September 10, 2019 to DMS Pharmaceutical Group by DLA Medical Directorate. There have been $1.6k in obligations to date with a ceiling value of $1.6k, showing a 100% burn rate so far on the contract. The contract was not competed under any preference program with 1 offer received.
DMS Pharmaceutical Group is a contractor located in IL, doing primarily Pharmaceuticals > Pharmaceutical Products work for Defense. The company receives $180.5M annually in federal awards (as of FY2020). Also, they have shown success winning IDC contracts concentrated mainly on a singular customer focused portfolio.
Purchase orders offer the Federal Government an avenue to streamline smaller purchases. Compared to the typical procurement process, where a requirement moves through several milestones before award, purchase orders allow for a quick turnaround to fulfill commodity and service needs. The total value of a transaction is the primary prerequisite for the use of purchase orders. In more familiar terms, purchase orders resemble a trip to a local retail store to buy a few items.
Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.
We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.
Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.
Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.
If you do business with the Federal Government, you need Federal Compass.
We are a public sector market intelligence and solutions platform for government contracting.